Evidence map›Paper›PMID 41877295›Full record

ArticleCell & bioscience2026

The molecular mechanism underlying the differential subcellular distribution of dystrophin Dp71 isoforms.

Alma Alamillo-Iniesta, Griselda Velez-Aguilera, Feliciano Monterrubio-Ledezma, Rodolfo Daniel Ávila-Avilés, Rocío Suárez-Sánchez, Ian García-Aguirre, Solangy Lizcano-Meneses, Tania I López-Orona, Francisco Guevara-Namorado, Alejandra Toribio-Valdez and 4 more

Abstract read
In one paragraph

Article in Cell & bioscience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Alma Alamillo-Iniesta *Departamento de Genética y Biología Molecular, Centro de Investigación y de Estudios Avanzados, Ciudad de México,, México.
Griselda Velez-Aguilera *Departamento de Genética y Biología Molecular, Centro de Investigación y de Estudios Avanzados, Ciudad de México,, México.
Feliciano Monterrubio-LedezmaDepartamento de Genética y Biología Molecular, Centro de Investigación y de Estudios Avanzados, Ciudad de México,, México.
Rodolfo Daniel Ávila-AvilésTransdisciplinary Research for Drug Discovery, Sociedad Mexicana de Epigenética y Medicina Regenerativa A. C. (SMEYMER), Ciudad de México,, México.
Rocío Suárez-SánchezLaboratorio de Medicina Genómica, Departamento de Genética, Instituto Nacional de Rehabilitación-Luis Guillermo Ibarra (INR-LGII), Ciudad de México,, México.
Ian García-AguirreDepartamento de Bioingeniería, Escuela de Ingeniería y Ciencias, Tecnológico de Monterrey, Campus Ciudad de México, Ciudad de México,, México.
Solangy Lizcano-MenesesDepartamento de Genética y Biología Molecular, Centro de Investigación y de Estudios Avanzados, Ciudad de México,, México.
Tania I López-OronaDepartamento de Genética y Biología Molecular, Centro de Investigación y de Estudios Avanzados, Ciudad de México,, México.
Francisco Guevara-NamoradoDepartamento de Genética y Biología Molecular, Centro de Investigación y de Estudios Avanzados, Ciudad de México,, México.
Alejandra Toribio-ValdezDepartamento de Genética y Biología Molecular, Centro de Investigación y de Estudios Avanzados, Ciudad de México,, México.
José Manuel Hernández-HernándezDepartamento de Genética y Biología Molecular, Centro de Investigación y de Estudios Avanzados, Ciudad de México,, México.
Isabel Arrieta-CruzDivisión de Investigación, Departamento de Investigación Básica, Instituto Nacional de Geriatría, Secretaría de Salud, Ciudad de México,, México.
Jonathan J MagañaLaboratorio de Medicina Genómica, Departamento de Genética, Instituto Nacional de Rehabilitación-Luis Guillermo Ibarra (INR-LGII), Ciudad de México,, México. jmagana@inr.gob.mx.ORCID http://orcid.org/0000-0003-4399-4618
Bulmaro CisnerosDepartamento de Genética y Biología Molecular, Centro de Investigación y de Estudios Avanzados, Ciudad de México,, México. bcisnero@cinvestav.mx.ORCID http://orcid.org/0000-0003-2802-1201

Funding

Consejo Nacional de Ciencia y Tecnología 237123Instituto Tecnológico y de Estudios Superiores de Monterrey CI_EIC_HLT_D_208
6 · The paper itself

Abstract

backgroundDystrophin Dp71 is a versatile protein that plays a critical role in regulating diverse processes, including cell adhesion, nuclear architecture, neuronal differentiation, and synapse organization. Moreover, Dp71 is involved in cognitive, retinal vascular and cancer diseases. This multifunctional role is believed to result from the alternative splicing undergoes by Dp71 transcript. As previously outlined, the splicing of exon 78 appears to influence the localization of Dp71 isoforms. Specifically, Dp71d, containing exon 78, shows nuclear localization, while Dp71f, lacking exon 78 and instead having 31 hydrophobic residues (founder sequence), shows cytoplasmic localization. We delineate the mechanism dictating the differential localization between Dp71 isoforms, using various reporter vectors, in combination with protein-protein interaction assays, site-directed mutagenesis on nuclear export signal (NES), knockdown experiments on importin α2 and CRM1 nuclear transporters, and molecular dynamic simulations.

resultsWe demonstrate that both Dp71d and Dp71f translocate to the nucleus via importin α2/β1, interact with nuclear proteins, and are exported through a shared NES in exon 77 (NES1). However, we identified and characterized a second NES (NES2) located at the founder sequence, that binds to the exportin CRM1 with higher affinity, and thereby drives efficient nuclear export of Dp71f.

conclusionsAlternative splicing at exon 78, generates an NES unique to Dp71f, which dictates subcellular localization and function of this isoform. As a result, Dp71f is efficiently exported and becomes predominantly cytoplasmic, whereas Dp71d, without this NES, is exported less efficiently and remains longer in the nucleus.

Indexed as

Dp71dDp71fDystrophin Dp71Importin α2Importin β1Leptomycin BNuclear export signal

Identifiers

PMID41877295
PMCPMC13137586

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.